Top

BMC Medicine

Published in:

Open Access 01-12-2022 | Research article

Prevalence and trend of smokeless tobacco use and its associated factors among adolescents aged 12–16 years in 138 countries/territories, 1999–2019

Authors: Hui Yang, Chuanwei Ma, Min Zhao, Costan G. Magnussen, Bo Xi

Published in: BMC Medicine | Issue 1/2022

Abstract

Background

Smokeless tobacco use is popular in some regions worldwide, but it receives less attention compared to cigarette smoking. We aimed to estimate the recent prevalence of, and trends in, smokeless tobacco use and to examine its associated factors among adolescents aged 12–16 years in 138 countries/territories (hereafter “countries”) from 1999 to 2019.

Methods

Data from the Global Youth Tobacco Survey conducted in 138 countries in 2010–2019 and the National Youth Tobacco Survey conducted in the United States in 2019 were used to calculate the prevalence of current smokeless tobacco use and investigate its associated factors among adolescents aged 12–16 years. We also assessed the trend in the prevalence of smokeless tobacco use in 100 countries that had conducted more than one survey from 1999 to 2019.

Results

The overall prevalence of current smokeless tobacco use was 4.4% (95% confidence interval [CI] 4.0–4.9), with 5.7% (5.1–6.3) for boys, 3.1% (2.6–3.5) for girls, 3.9% (3.5–4.4) for adolescents aged 12–14 years and 5.4% (4.8–5.9) for those aged 15–16 years. The prevalence was highest in the South-East Asian region (6.1%, 4.4–7.7) and lowest in the Western Pacific region (2.0%, 1.7–2.4). The prevalence of smokeless tobacco use decreased in 57 of 100 countries, increased in 32 countries, and remained unchanged in 11 countries. Current cigarette smoking (odds ratio [OR]=2.00, 95% CI=1.68–2.39), other tobacco product use (OR=6.03, 95% CI=4.92–7.40), tobacco advertisement exposure (OR=1.44, 95% CI=1.19–1.74), being offered free tobacco products (OR=2.01, 95% CI=1.66–2.42), and not being taught about dangers of smoking (OR=1.28, 95% CI=1.09–1.50) were all positively associated with current smokeless tobacco use.

Conclusions

Smokeless tobacco use among adolescents remains a public health concern worldwide. Although the prevalence among adolescents decreased in most countries, it remains high especially in the South-East Asian region. More strict and effective strategies and measures are needed to further curb the smokeless tobacco use among adolescents.

Available only for authorised users

Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc. 2014;11(2):231–5. https://doi.org/10.1513/AnnalsATS.201312-433PS.CrossRefPubMed

Johnson AL, Collins LK, Villanti AC, Pearson JL, Niaura RS. Patterns of Nicotine and Tobacco Product Use in Youth and Young Adults in the United States, 2011-2015. Nicotine Tob Res. 2018;20(Suppl 1):48–54. https://doi.org/10.1093/ntr/nty018.CrossRef

Hair EC, Romberg AR, Niaura R, Abrams DB, Bennett MA, Xiao H, et al. Longitudinal Tobacco Use Transitions Among Adolescents and Young Adults: 2014-2016. Nicotine Tob Res. 2019;21(4):458–68. https://doi.org/10.1093/ntr/ntx285.CrossRefPubMed

Tam J. E-cigarette, combustible, and smokeless tobacco product use combinations among youth in the united states, 2014-2019. Addict Behav. 2021;112:106636. https://doi.org/10.1016/j.addbeh.2020.106636.CrossRefPubMed

Lund I, Scheffels J. Adolescent tobacco use practices and user profiles in a mature Swedish moist snuff (snus) market: Results from a school-based cross-sectional study. Scand J Public Health. 2016;44(7):646–53. https://doi.org/10.1177/1403494816656093.CrossRefPubMed

Sinha DN, Gupta PC, Kumar A, Bhartiya D, Agarwal N, Sharma S, et al. The Poorest of Poor Suffer the Greatest Burden From Smokeless Tobacco Use: A Study From 140 Countries. Nicotine Tob Res. 2018;20(12):1529–32. https://doi.org/10.1093/ntr/ntx276.CrossRefPubMed

Sinha DN, Suliankatchi RA, Gupta PC, Thamarangsi T, Agarwal N, Parascandola M, et al. Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018;27(1):35–42. https://doi.org/10.1136/tobaccocontrol-2016-053302.CrossRefPubMed

Drope J, Schluger N, Cahn Z, Drope J, Hamill S, Islami F, et al. The Tobacco Atlas. 6th ed. Atlanta: American Cancer Society and Vital Strategies; 2018.

Siddiqi K, Husain S, Vidyasagaran A, Readshaw A, Mishu MP, Sheikh A. Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries. BMC Med. 2020;18(1):222. https://doi.org/10.1186/s12916-020-01677-9.CrossRefPubMedPubMedCentral

10.

World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89. In: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosaminespdf icon, vol. 89. Lyon (France): World Health Organization, International Agency for Research on Cancer; 2007.

11.

U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

12.

Connolly GN, Richter P, Aleguas AJ, Pechacek TF, Stanfill SB, Alpert HR. Unintentional child poisonings through ingestion of conventional and novel tobacco products. Pediatrics. 2010;125(5):896–9. https://doi.org/10.1542/peds.2009-2835.CrossRefPubMed

13.

Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122(15):1520–44. https://doi.org/10.1161/CIR.0b013e3181f432c3.CrossRefPubMed

14.

Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Scientific opinion on the Health Effects of Smokeless Tobacco Products. Brussels: European Commission, SCENIHR; 2008.

15.

Carlsson S, Andersson T, Araghi M, Galanti R, Lager A, Lundberg M, et al. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts. J Intern Med. 2017;281(4):398–406. https://doi.org/10.1111/joim.12592.CrossRefPubMed

16.

U.S. Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.

17.

Centers for Disease Control and Prevention (CDC). Use of cigarettes and other tobacco products among students aged 13-15 years--worldwide, 1999-2005. MMWR-Morbdi Mortal W. 2006;55(20):553–6.

18.

Sinha DN, Kumar A, Bhartiya D, Sharma S, Gupta PC, Singh H, et al. Smokeless Tobacco Use Among Adolescents in Global Perspective. Nicotine Tob Res. 2017;19(11):1395–6. https://doi.org/10.1093/ntr/ntx004.CrossRefPubMed

19.

National Cancer Institute and Centers for Disease Control and Prevention. Smokeless Tobacco and Public Health: A Global Perspective. Bethesda: Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute; 2014.

20.

Mehrotra R, Yadav A, Sinha DN, Parascandola M, John RM, Ayo-Yusuf O, et al. Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures. Lancet Oncol. 2019;20(4):e208–17. https://doi.org/10.1016/s1470-2045(19)30084-1.CrossRefPubMed

21.

Zaatari GS, Bazzi A. Impact of the WHO FCTC on non-cigarette tobacco products. Tob Control. 2019;28(Suppl 2):104–12. https://doi.org/10.1136/tobaccocontrol-2018-054346.CrossRef

22.

Reddy PS, James S, Resnicow K, Sewpaul R, Masuka P, van den Borne B. Prevalence and correlates of smokeless tobacco use among grade 8-11 school students in South Africa: a nationwide study. Nicotine Tob Res. 2014;16(9):1167–73. https://doi.org/10.1093/ntr/ntu044.CrossRefPubMed

23.

Sharma AD, Garg S, Singh MM, Deshmukh CP, Sharma P, Borle AL. Prevalence and Social Contextual Factors of Smokeless Tobacco Use: Insights from Schools of Delhi. India. Asian Pac J Cancer Prev. 2021;22(8):2351–5. https://doi.org/10.31557/APJCP.2021.22.8.2351.CrossRefPubMed

24.

Othman M, Farid NDN, Aghamohammadi N, Danaee M. Determinants of smokeless tobacco use and prevalence among Sudanese adolescents. Arch Public Health. 2021;79(1):176. https://doi.org/10.1186/s13690-021-00699-w.CrossRefPubMedPubMedCentral

25.

Tam J, Day HR, Rostron BL, Apelberg BJ. A systematic review of transitions between cigarette and smokeless tobacco product use in the United States. BMC Public Health. 2015;15:258. https://doi.org/10.1186/s12889-015-1594-8.CrossRefPubMedPubMedCentral

26.

Grotvedt L, Forsen L, Ariansen I, Graff-Iversen S, Lingaas HT. Impact of snus use in teenage boys on tobacco use in young adulthood; a cohort from the HUNT Study Norway. BMC Public Health. 2019;19(1):1265. https://doi.org/10.1186/s12889-019-7584-5.CrossRefPubMedPubMedCentral

27.

Warren CW. Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet. 2006;367(9512):749–53. https://doi.org/10.1016/S0140-6736(06)68192-0.CrossRefPubMed

28.

Centers for Disease Control and Prevention (CDC). Global Tobacco Surveillance System Data (GTSSData). https://www.cdc.gov/tobacco/global/gtss/gtssdata/index.html (2021).

29.

Centers for Disease Control and Prevention (CDC). National Youth Tobacco Survey (NYTS). https://www.cdc.gov/tobacco/data_statistics/surveys/nyts/index.htm (2022).

30.

Liang X, Xiao L, Jiang Y, editors. Chinese Youth tobacco Survey report 2014. 1st ed. Beijing: People’s Medical Publishing House; 2014.

31.

Sinha DN, Agarwal N, Gupta PC. Prevalence of smokeless tobacco use and number of users in 121 countries. BIMMR. 2015;9(6):1–20. https://doi.org/10.9734/BJMMR/2015/16285.CrossRef

32.

Gordon J, Biglan A, Smolkowski K. The impact on tobacco use of branded youth anti-tobacco activities and family communications about tobacco. Prev Sci. 2008;9(2):73–87. https://doi.org/10.1007/s11121-008-0089-6.CrossRefPubMedPubMedCentral

33.

Brener ND, Collins JL, Kann L, Warren CW, Williams BI. Reliability of the youth risk behavior survey questionnaire. Am J Epidemiol. 1995;141(6):575–80. https://doi.org/10.1093/oxfordjournals.aje.a117473.CrossRefPubMed

Title: Prevalence and trend of smokeless tobacco use and its associated factors among adolescents aged 12–16 years in 138 countries/territories, 1999–2019
Authors: Hui Yang
Chuanwei Ma
Min Zhao
Costan G. Magnussen
Bo Xi
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-022-02662-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prevalence and trend of smokeless tobacco use and its associated factors among adolescents aged 12–16 years in 138 countries/territories, 1999–2019

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker

Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study

A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society

Economic evaluation of COVID-19 rapid antigen screening programs in the workplace

Modified cardiovascular SOFA score in sepsis: development and internal and external validation